Sequence information
Variant position: 784 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 893 The length of the canonical sequence.
Location on the sequence:
KDVTILAATNRPDRIDKALM
R PGRIDRIIYVPLPDAATRRE
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human KDVTILAATNRPDRIDKALMR PGRIDRIIYVPLPDAATRRE
Mouse KNVTVLAATNRPDRIDKALMR PGRIDRIIYVPLPDAATRRE
Caenorhabditis elegans SRVILLAATNRPDQLDSALLR PGRLDRAIYVGLPCEVTRRA
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 893
ATPase family protein 2 homolog
Alternative sequence
697 – 893
Missing. In isoform 3.
Alternative sequence
781 – 790
ALMRPGRIDR -> VPPSQTFLLL. In isoform 2.
Literature citations
Mutations in SPATA5 are associated with microcephaly, intellectual disability, seizures, and hearing loss.
Tanaka A.J.; Cho M.T.; Millan F.; Juusola J.; Retterer K.; Joshi C.; Niyazov D.; Garnica A.; Gratz E.; Deardorff M.; Wilkins A.; Ortiz-Gonzalez X.; Mathews K.; Panzer K.; Brilstra E.; van Gassen K.L.; Volker-Touw C.M.; van Binsbergen E.; Sobreira N.; Hamosh A.; McKnight D.; Monaghan K.G.; Chung W.K.;
Am. J. Hum. Genet. 97:457-464(2015)
Cited for: INVOLVEMENT IN EHLMRS; VARIANTS EHLMRS GLN-84; ILE-90; THR-100; THR-330 DEL; LEU-448; LEU-488; GLN-529; CYS-626; GLY-628; GLN-784 AND VAL-844;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.